Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy

Detalles Bibliográficos
Autor principal: Gök Sargın, Zeynep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152158/
https://www.ncbi.nlm.nih.gov/pubmed/36919836
http://dx.doi.org/10.5152/tjg.2023.23070
_version_ 1785035693919043584
author Gök Sargın, Zeynep
author_facet Gök Sargın, Zeynep
author_sort Gök Sargın, Zeynep
collection PubMed
description
format Online
Article
Text
id pubmed-10152158
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Turkish Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-101521582023-05-03 Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy Gök Sargın, Zeynep Turk J Gastroenterol Letter to the Editor Turkish Society of Gastroenterology 2023-03-01 /pmc/articles/PMC10152158/ /pubmed/36919836 http://dx.doi.org/10.5152/tjg.2023.23070 Text en 2023 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Letter to the Editor
Gök Sargın, Zeynep
Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
title Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
title_full Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
title_fullStr Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
title_full_unstemmed Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
title_short Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
title_sort risk of reactivation of hepatitis b in hepatitis b surface antigen-negative and hepatitis b core antigen antibody positive patients receiving biologic therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152158/
https://www.ncbi.nlm.nih.gov/pubmed/36919836
http://dx.doi.org/10.5152/tjg.2023.23070
work_keys_str_mv AT goksargınzeynep riskofreactivationofhepatitisbinhepatitisbsurfaceantigennegativeandhepatitisbcoreantigenantibodypositivepatientsreceivingbiologictherapy

Ejemplares similares